| Bioactivity | 3′-Deoxy-3′-fluoroguanosine exhibits antiviral activity against tick-borne encephalitis virus (TBEV), through interaction with NS5B RdRp of HCV, resulting in suppression of viral RNA synthesis by disruption of further extension of the replicating viral RNA[1]. |
| CAS | 123402-21-1 |
| Formula | C10H12FN5O4 |
| Molar Mass | 285.23 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Eyer L, et al., Broad-Spectrum Antiviral Activity of 3'-Deoxy-3'-Fluoroadenosine against Emerging Flaviviruses. Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01522-20. |
3′-Deoxy-3′-fluoroguanosine
CAS: 123402-21-1 F: C10H12FN5O4 W: 285.23
3′-Deoxy-3′-fluoroguanosine exhibits antiviral activity against tick-borne encephalitis virus (TBEV), through interact
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.